Table 1.
Baseline demographic and clinical characteristics of the included patients of both groups.
| Characteristics | C-PRP Group (n = 46) |
A-PRP Group (n = 50) |
p Value |
|---|---|---|---|
| Men/Women | 26/20 | 34/16 | n.s. |
| Age, y (mean ± SD) | 47.1 ± 11.9 | 49.5 ± 12.2 | n.s. |
| Previous Surgery (yes/no) | 16/30 | 13/37 | n.s. |
| Tonnis OA Grade | Grade 1: 6 | Grade 1: 5 | n.s. |
| Grade 2: 19 | Grade 2: 23 | ||
| Grade 3: 21 | Grade 3: 22 | ||
| VAS pain | 37.2 ± 22.0 | 31.8 ± 19.9 | n.s. |
| WOMAC | 27.9 ± 17.2 | 27.1 ± 17.6 | n.s. |
| HHS | 78.6 ± 11.4 | 83.8 ± 11.9 | 0.026 |
A-PRP, Autologous PRP; C-PRP, cord PRP; HHS, Harris Hip Score; n.s., not significant; OA, osteoarthritis; SD, standard deviation; VAS, Visual Analogue Scale; WOMAC, Western Ontario and McMaster University Osteoarthritis index; y, years.